Arcellx(us:ACLX)
60.70
-7.47%
Updated on 2025-04-02
Open:65.55
Close:60.70
High:65.55
Low:59.52
Prev Close:65.60
Volume:1.06M
Turnover:65.00M
Turnover Ratio:1.92%
Shares:54.94M
MarketCap:3.34B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 6 | 20575 | 0.04% | 0 | 2 | 2 |
| 2024-03-31 | 189 | 46965250 | 88.14% | 38 | 69 | 68 |
| 2023-12-31 | 173 | 46735291 | 89.39% | 36 | 60 | 65 |
| 2023-09-30 | 151 | 47555252 | 97.70% | 17 | 58 | 56 |
| 2023-06-30 | 147 | 48164375 | 99.69% | 32 | 66 | 42 |
| 2023-03-31 | 136 | 45475000 | 95.05% | 15 | 46 | 62 |
| 2022-12-31 | 127 | 41874621 | 94.94% | 54 | 35 | 32 |
| 2022-09-30 | 86 | 41652038 | 95.00% | 18 | 35 | 28 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Fmr Llc | 5394495 | 10.12% | 1015326 | 23.18% |
| 2024-03-31 | Perceptive Advisors Llc | 3933556 | 7.38% | -611253 | -13.45% |
| 2024-03-31 | Paradigm Biocapital Advisors Lp | 3818095 | 7.17% | 159471 | 4.36% |
| 2024-03-31 | Nea Management Company, Llc | 3745262 | 7.03% | 0 | |
| 2024-03-31 | Blackrock Inc. | 3066068 | 5.75% | 47530 | 1.57% |
| 2024-03-31 | Sr One Capital Management, Lp | 2346630 | 4.40% | -800000 | -25.42% |
| 2024-03-31 | Vanguard Group Inc | 2228856 | 4.18% | 167037 | 8.10% |
| 2024-03-31 | State Street Corp | 1885118 | 3.54% | 111279 | 6.27% |
| 2024-03-31 | Cormorant Asset Management, Lp | 1780000 | 3.34% | 80000 | 4.71% |
| 2024-03-31 | Suvretta Capital Management, Llc | 1562354 | 2.93% | -873620 | -35.86% |
About
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
Address:25 West Watkins Mill Road,Suite A
Website:http://www.arcellx.com
Market Movers